Award
National Cancer Institute 4R01CA276846-03
Preventing invasive prostate cancer
Recipient
University of Nebraska Medical Center, Omaha, NE
Award Amount
$1,607,348.00
Ceiling
$1,607,348.00
Awarded
September 18, 2025
Identifier
4R01CA276846-03
A research project funded by the National Cancer Institute to develop a drug that prevents prostate cancer metastasis by inhibiting cell movement.
Description
This project aims to test a novel drug that inhibits prostate cancer cell movement to prevent metastasis. The research involves identifying the drug's binding site, characterizing the signaling pathway involved in cell motility, and evaluating efficacy in relevant models.